Logo image of SG

SWEETGREEN INC - CLASS A (SG) Stock Fundamental Analysis

NYSE:SG - New York Stock Exchange, Inc. - US87043Q1085 - Common Stock - Currency: USD

12.6  -0.21 (-1.64%)

Premarket: 12.65 +0.05 (+0.4%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to SG. SG was compared to 134 industry peers in the Hotels, Restaurants & Leisure industry. SG scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, SG is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year SG has reported negative net income.
SG had a positive operating cash flow in the past year.
SG had negative earnings in each of the past 5 years.
In multiple years SG reported negative operating cash flow during the last 5 years.
SG Yearly Net Income VS EBIT VS OCF VS FCFSG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

SG has a worse Return On Assets (-10.71%) than 85.07% of its industry peers.
SG has a Return On Equity (-20.65%) which is in line with its industry peers.
Industry RankSector Rank
ROA -10.71%
ROE -20.65%
ROIC N/A
ROA(3y)-14.91%
ROA(5y)-23.59%
ROE(3y)-26.31%
ROE(5y)-34.72%
ROIC(3y)N/A
ROIC(5y)N/A
SG Yearly ROA, ROE, ROICSG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

The Gross Margin of SG (28.44%) is worse than 79.85% of its industry peers.
In the last couple of years the Gross Margin of SG has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for SG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.09%
GM growth 5Y-0.69%
SG Yearly Profit, Operating, Gross MarginsSG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

6

2. Health

2.1 Basic Checks

SG does not have a ROIC to compare to the WACC, probably because it is not profitable.
SG has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SG has been increased compared to 5 years ago.
SG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SG Yearly Shares OutstandingSG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SG Yearly Total Debt VS Total AssetsSG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 1.31, we must say that SG is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.31, SG perfoms like the industry average, outperforming 44.03% of the companies in the same industry.
SG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.31
ROIC/WACCN/A
WACC9.15%
SG Yearly LT Debt VS Equity VS FCFSG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.97 indicates that SG should not have too much problems paying its short term obligations.
With an excellent Current ratio value of 1.97, SG belongs to the best of the industry, outperforming 83.58% of the companies in the same industry.
A Quick Ratio of 1.95 indicates that SG should not have too much problems paying its short term obligations.
The Quick ratio of SG (1.95) is better than 84.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.97
Quick Ratio 1.95
SG Yearly Current Assets VS Current LiabilitesSG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.47% over the past year.
The Revenue has grown by 11.11% in the past year. This is quite good.
The Revenue has been growing by 19.81% on average over the past years. This is quite good.
EPS 1Y (TTM)10.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.7%
Revenue 1Y (TTM)11.11%
Revenue growth 3Y25.81%
Revenue growth 5Y19.81%
Sales Q2Q%5.36%

3.2 Future

The Earnings Per Share is expected to grow by 20.44% on average over the next years. This is a very strong growth
SG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.36% yearly.
EPS Next Y18.18%
EPS Next 2Y18.3%
EPS Next 3Y18.73%
EPS Next 5Y20.44%
Revenue Next Year10.49%
Revenue Next 2Y15.13%
Revenue Next 3Y16.68%
Revenue Next 5Y19.36%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SG Yearly Revenue VS EstimatesSG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
SG Yearly EPS VS EstimatesSG Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -2 -4

0

4. Valuation

4.1 Price/Earnings Ratio

SG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SG Price Earnings VS Forward Price EarningsSG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SG Per share dataSG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

SG's earnings are expected to grow with 18.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.3%
EPS Next 3Y18.73%

0

5. Dividend

5.1 Amount

SG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SWEETGREEN INC - CLASS A

NYSE:SG (5/27/2025, 8:04:01 PM)

Premarket: 12.65 +0.05 (+0.4%)

12.6

-0.21 (-1.64%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-08 2025-08-08/amc
Inst Owners99.97%
Inst Owner Change11.53%
Ins Owners1.75%
Ins Owner Change-0.32%
Market Cap1.48B
Analysts82
Price Target29.92 (137.46%)
Short Float %16.56%
Short Ratio3.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.76%
Min EPS beat(2)-14.78%
Max EPS beat(2)9.26%
EPS beat(4)1
Avg EPS beat(4)-16.17%
Min EPS beat(4)-32.59%
Max EPS beat(4)9.26%
EPS beat(8)2
Avg EPS beat(8)-15.06%
EPS beat(12)5
Avg EPS beat(12)-9.11%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.86%
Min Revenue beat(2)-3.52%
Max Revenue beat(2)-2.2%
Revenue beat(4)0
Avg Revenue beat(4)-2.62%
Min Revenue beat(4)-3.91%
Max Revenue beat(4)-0.84%
Revenue beat(8)1
Avg Revenue beat(8)-2.61%
Revenue beat(12)1
Avg Revenue beat(12)-3.84%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-9.9%
PT rev (3m)-27.39%
EPS NQ rev (1m)-64.01%
EPS NQ rev (3m)-155.62%
EPS NY rev (1m)-5.62%
EPS NY rev (3m)-38.89%
Revenue NQ rev (1m)-5.78%
Revenue NQ rev (3m)-8.72%
Revenue NY rev (1m)-2.25%
Revenue NY rev (3m)-5.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.16
P/FCF N/A
P/OCF 55.24
P/B 3.43
P/tB 3.97
EV/EBITDA N/A
EPS(TTM)-0.77
EYN/A
EPS(NY)-0.47
Fwd EYN/A
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)0.23
OCFY1.81%
SpS5.82
BVpS3.68
TBVpS3.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.71%
ROE -20.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.44%
FCFM N/A
ROA(3y)-14.91%
ROA(5y)-23.59%
ROE(3y)-26.31%
ROE(5y)-34.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.09%
GM growth 5Y-0.69%
F-Score6
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 141.72%
Cap/Sales 14.07%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.97
Quick Ratio 1.95
Altman-Z 1.31
F-Score6
WACC9.15%
ROIC/WACCN/A
Cap/Depr(3y)172.66%
Cap/Depr(5y)198.17%
Cap/Sales(3y)17.26%
Cap/Sales(5y)20.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.7%
EPS Next Y18.18%
EPS Next 2Y18.3%
EPS Next 3Y18.73%
EPS Next 5Y20.44%
Revenue 1Y (TTM)11.11%
Revenue growth 3Y25.81%
Revenue growth 5Y19.81%
Sales Q2Q%5.36%
Revenue Next Year10.49%
Revenue Next 2Y15.13%
Revenue Next 3Y16.68%
Revenue Next 5Y19.36%
EBIT growth 1Y12.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year135.06%
EBIT Next 3Y47.21%
EBIT Next 5Y36.25%
FCF growth 1Y51.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y192.51%
OCF growth 3YN/A
OCF growth 5YN/A